CALR and atherosclerosis: Although G-Ro has antiplatelet effects, if G-Ro does not inhibit inflammation by leukocyte, the progression of atherosclerosis lesion would be generated at site of vascular wall injury, and a question for antiplatelet effects of G-Ro might be raised.